Extract

This a Phase III trial designed to determine if IV casopitant plus dexamethasone and ondansetron is more effective in the prevention of vomiting and nausea then dexamethasone and ondansetrone alone following the administration of moderately emetogenic oxaliplatin-based chemotherapy.

Inclusion criteria

• Nausea and vomiting ,Nausea and Vomiting, Chemotherapy-Induced

Country

• Belgium
• Bulgaria
• Canada
• Czech Republic
• Germany
• Hungary
• Italy
• Korea, Republic of
• Russian Federation
• Slovakia
• United States

Links

• nct
• ictrp